Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04920474 · ClinicalTrials.gov registry record

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

A clinical trial of Allogeneic Stem Cell Transplantation and Autologous Stem Cell Transplantation, sponsored by Center for International Blood and Marrow Transplant Research.

Recruiting
Registry status
1
Study location

NCT04920474: Recruiting study of Allogeneic Stem Cell Transplantation and Autologous Stem Cell Transplantation, sponsored by Center for International Blood and Marrow Transplant Research.

NCT04920474 is a study of Allogeneic Stem Cell Transplantation and Autologous Stem Cell Transplantation that is actively recruiting participants, run by Center for International Blood and Marrow Transplant Research. The registry lists this as an open-ended (no fixed target) study. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04920474, a study of Allogeneic Stem Cell Transplantation and Autologous Stem Cell Transplantation, is actively recruiting participants, sponsored by Center for International Blood and Marrow Transplant Research.

RECRUITING
Registry status
open-ended (no fixed target)
Enrollment target
1
Study location

Study Summary

The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellular therapy. Representatives of participating centers and investigators or research groups may request access to research samples contained in the Research Sample Repository for the purpose of conducting research including: * investigating molecular explanations for histocompatibility or clinical outcomes through analysis of genomic, epigenetic, or other biomolecular data * evaluating the factors that affect transplant or cellular therapy outcome * studying the distribution of HLA tissue types in different populations * studying the success of transplantation, cellular therapies or supportive care in the management of marrow toxic injuries * performing de-linked (anonymous) research

Conditions Studied

Allogeneic Stem Cell Transplantation Autologous Stem Cell Transplantation Cellular Therapy Marrow Toxic Injury

Study Locations (1)

Minnesota

  • NMDP Biorepository - New Brighton

Trial Details

FieldValue
Enrollment Target open-ended (no fixed target)
Start Date 1991-07
Est. Completion 2030-07
Center for International Blood and Marrow Transplant Research

29 total trials

What NCT04920474 shows while recruiting

NCT04920474 is an observational study that tracks outcomes without assigning an intervention. The registry lists this as an open-ended (no fixed target) study, common for long-running registries that collect data indefinitely.

The record links to 4 conditions, with Allogeneic Stem Cell Transplantation appearing as the primary indexed condition, and to 0 interventions.

NCT04920474 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT04920474 about?

NCT04920474 is a clinical study titled "Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries". The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellular therapy. Representatives of participating centers and investigators or research groups may reque...

What is the current status of trial NCT04920474?

This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 1991-07. Estimated completion is 2030-07.

What conditions does trial NCT04920474 study?

This clinical trial studies the following conditions: Allogeneic Stem Cell Transplantation, Autologous Stem Cell Transplantation, Cellular Therapy, Marrow Toxic Injury.

Who is sponsoring clinical trial NCT04920474?

This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04920474 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Allogeneic Stem Cell Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

More recruiting context for NCT04920474

Source: ClinicalTrials.gov NCT04920474, the US trial registry maintained by the National Library of Medicine. NCT04920474 (unsized enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.